MetaVia Inc (MTVA)
2.14
+0.03
(+1.42%)
USD |
NASDAQ |
Jan 03, 16:00
2.08
-0.06
(-2.80%)
After-Hours: 20:00
MetaVia Research and Development Expense (Quarterly): 4.517M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
Dermata Therapeutics Inc | 2.401M |
Cognition Therapeutics Inc | 11.39M |
ZyVersa Therapeutics Inc | 0.436M |
Cytokinetics Inc | -- |
Ocugen Inc | 8.108M |